Main menu button

News

Analysis, Brighter: 10,9,8.... launch
10 Oct 2017
Analysis, Brighter: 10,9,8.... launch
Equity Research
Analysis, Maxkompetens: Undiscovered growth
04 Oct 2017
Analysis, Maxkompetens: Undiscovered growth
Equity Research
Analysis, Kopy Goldfields: Increased Resources Bode Well
02 Oct 2017
Analysis, Kopy Goldfields: Increased Resources Bode Well
Equity Research
Analysis, Pharmacolog: Refreshing capital injection
28 Sep 2017
Analysis, Pharmacolog: Refreshing capital injection
Equity Research
Comment Q1: Maxkompetens, better than expected
28 Sep 2017
Comment Q1: Maxkompetens, better than expected
Equity Research
Analysis, GHP Specialty Care: Weakness creates opportunity
26 Sep 2017
Analysis, GHP Specialty Care: Weakness creates opportunity
Equity Research
Preview, Maxkompetens Q1
26 Sep 2017
Preview, Maxkompetens Q1
Equity Research
Analysis, Nuevolution: Strong year adds confidence
20 Sep 2017
Analysis, Nuevolution: Strong year adds confidence
Equity Research
Analysis, MaxFastigheter: Best yield-arbitrage in the sector
18 Sep 2017
Analysis, MaxFastigheter: Best yield-arbitrage in the sector
Equity Research
Analysis, SpectraCure: Progress with thumbs upp
15 Sep 2017
Analysis, SpectraCure: Progress with thumbs upp
Equity Research
Analysis, Miris: Better sales while waiting for FDA
14 Sep 2017
Analysis, Miris: Better sales while waiting for FDA
Equity Research
Analysis, Gapwaves: Stort intresse kräver satsning
06 Sep 2017
Analysis, Gapwaves: Stort intresse kräver satsning
Equity Research
Analysis, Hanza: Increased proftability despite increase input costs
06 Sep 2017
Analysis, Hanza: Increased proftability despite increase input costs
Equity Research
Analysis, CLS: Reduced costs in Q2
04 Sep 2017
Analysis, CLS: Reduced costs in Q2
Equity Research
Analys, Boule Diagnostics: Margins took a hit
30 Aug 2017
Analys, Boule Diagnostics: Margins took a hit
Equity Research
Analysis, Sonetel: Increasing cost for growth
30 Aug 2017
Analysis, Sonetel: Increasing cost for growth
Equity Research
Analysis, Cherry: Yggdrasil and PBM on a roll
30 Aug 2017
Analysis, Cherry: Yggdrasil and PBM on a roll
Equity Research
Analysis, Consilium: Investing in a weak market
29 Aug 2017
Analysis, Consilium: Investing in a weak market
Equity Research
Analysis, Wilson Therapeutics: Promising ahead of autumn
28 Aug 2017
Analysis, Wilson Therapeutics: Promising ahead of autumn
Equity Research
Analysis, TargetEveryone: Fokus on margins again
25 Aug 2017
Analysis, TargetEveryone: Fokus on margins again
Equity Research